|
Volumn 497, Issue 1, 2001, Pages 50-54
|
Design and production of genetically modified soybean protein with anti-hypertensive activity by incorporating potent analogue of ovokinin(2-7)
|
Author keywords
Anti hypertensive peptide; Genetically modified food; Ovokinin; Soybean conglycinin; Spontaneously hypertensive rat
|
Indexed keywords
ARGINYLPROLYLLEUCYLLYSYLPROLYLTRYPTOPHAN;
CHYMOTRYPSIN;
KININ DERIVATIVE;
OVOKININ;
SOYBEAN PROTEIN;
TRYPSIN;
UNCLASSIFIED DRUG;
ALPHA CHAIN;
AMINO ACID SEQUENCE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
ESCHERICHIA COLI;
HYPERTENSION;
ION EXCHANGE CHROMATOGRAPHY;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN METABOLISM;
SITE DIRECTED MUTAGENESIS;
ADMINISTRATION, ORAL;
AMINO ACID MOTIFS;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CHYMOTRYPSIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DESIGN;
EGG PROTEINS;
ELECTROPHORESIS, POLYACRYLAMIDE GEL;
GLOBULINS;
MOLECULAR SEQUENCE DATA;
MUTAGENESIS, SITE-DIRECTED;
PEPTIDE FRAGMENTS;
PRODRUGS;
PROTEIN ENGINEERING;
PROTEIN SUBUNITS;
RATS;
RATS, INBRED SHR;
RECOMBINANT PROTEINS;
SOYBEAN PROTEINS;
SOYBEANS;
TRYPSIN;
ESCHERICHIA COLI;
GLYCINE MAX;
|
EID: 0035907064
PISSN: 00145793
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-5793(01)02434-6 Document Type: Article |
Times cited : (69)
|
References (18)
|